Structuring and strengthening an ecosystem for biotherapies and bioproduction
Biotherapies comprise treatments derived from biological entities such as bacteria, viruses or animal cells that are genetically modified then cultured in mass in bioreactors. They, and their industrial production, called bioproduction, are key sectors for the future of the pharmaceutical industry. Biotherapies play a role in the technological, economic and healthcare independence of France. Paris Region is a major actor in certain biotherapies, particularly gene and cell therapies. However, the region needs to strengthen its capacities in bioproduction and ensure this latter's future by training tomorrow's talents.
This study is linked to the following theme :
Paris Region: at the cutting edge of biotechnologies and gene & cell therapies
Note rapide Economy, #33
Paris Region is a hub of scientific excellence and furthermore home to numerous competencies in the strategic sector of next-generation biological medicines. Public-private partnerships for biotherapy R&D benefit greatly from the presence of large biopharmaceutical groups in ...
The healthcare industry in the Paris Region: a powerful sector facing strategic challenges
Note rapide Economy, #30
Healthcare players in the Paris Region benefit from a very favourable environment, featuring: internationally recognised scientific research; state-of-the-art hospitals; business incubators and institutional support. The number of R&D personnel has doubled in key sectors ...